The BrainSpan transcriptome database (http://www.brainspan.org) was used to build 1 4 9
developing human brain networks [22] . Data from eight post-conceptual weeks to 40 1 5 0 years of age were analyzed. A total of 385 samples were used for the analysis after 1 5 1 combining the multiplicates by taking mean values. Probes with TPM (transcripts per 1 5 2 million) > 5 in at least one sample were used, yielding 23,943 probes as "brain- Variants were first filtered by gnomAD allele frequency of 0.001 in a heterozygous 1 7 0 status and ability to alter protein sequences. Then CH variants were called on a trio 1 7 1
setting. If a gene contains more than one filtered variant and each variant was inherited 1 7 2 from mother and father separately (for proband), or at least one but not all of the 1 7 3 filtered variants of a gene were found from the progeny (for parent), the variants were Additional file: Figure S2 ). The distribution of straight-line distances from home to the 1 8 9
clinic strongly correlates with the original population distribution of Korea, 1 9 0 demonstrating that our cohort covers the entire population (Table 1 , Additional file: 1 9 1 Figure S3 ).
9 2
The majority of the patients is sporadic origin (504/553 = 91.1%; Fig. 1a Table S1 ), in which 20 CNVs originated de novo (3.6% of the entire cohort), which is 1 9 9 slightly lower but comparable to a previous observation [24] . Three inherited 2 0 0 pathogenic CNVs were identified: a 165.5 kb deletion in a large family containing 2 0 1 multiple affected individuals (Additional file: Figure S4 ), and 7.2 Mb and 203.2 kb 2 0 2 hemizygous duplications that were transmitted from healthy moms to their affected 2 0 3 sons (Additional file: Table S1 ). An additional 7.1% of the cohort (39 patients) harbored 2 0 4 previously reported variants that were assumed to be pathogenic but displayed distinct 2 0 5 phenotypes, potentially expanding the phenotypic spectrum associated with these 2 0 6
genes. For example, two patients that carried a pathogenic heterozygous nonsense or 2 0 7 missense variant in COL1A1, known to cause osteogenesis imperfecta [25], were 2 0 8
initially diagnosed with muscle hypotonia. These two patients did not display skeletal 2 0 9
problems, but showed blue sclera [26] . Adding this group to the high confidence group 2 1 0 yielded an instant diagnostic rate of 47.4% ("known genes"; Additional file: Table S2 ).
1 1
Finally, an additional 10.1% of the cohort (56 patients, 53 genes) harbored variants that 2 1 2 are highly likely to be pathogenic but their disease associations are elusive ("novel 2 1 3 genes"), yielding a "suggestive" diagnostic yield of 57.5% (Fig. 1c ). Among the patients 2 1 4
with definite diagnosis, 35.1% are recessive, and 29.9% harbored loss-of-function (LoF) 2 1 5 variants ( Fig. 1d and Additional file: Figure S5 ). As expected, the known genes showed 2 1 6 strong enrichment in disease categories and gene ontologies such as intellectual 2 1 7 disability and central nervous system (CNS) development ( Fig. 1e ).
2 1 8 2 1 9
Novel genes display potential enrichment in neuronal differentiation 2 2 0
We assessed whether the 53 novel genes possess a neurologic disease-causing 2 2 1 function. The novel gene set was simulated against the BrainSpan data (Materials and 2 2 2 Methods) to evaluate if the expression of these novel genes as a group was strongly 2 2 3 correlated with known disease-associated genes during brain development. After 10 5 2 2 4 permutations, we found that the observed involvement of the novel genes was 2 2 5 significantly stronger than a randomly selected gene sets across eight developmental 2 2 6 windows ( Fig. 1f did not reveal any difference in burden ( Fig. 2a and Additional file: Figure S6 ), implying in the C-terminal portion, as compared to the dominant genes ( Fig. 2g ). There was no 2 7 2 significant difference in basic clinical parameters (displayed in 
1 5
Consistent with previous studies, we were able to diagnose approximately half 3 1 6 of the KND patients ( Fig. 1c ) [10-12, 14, 16] . The novel genes formed significantly 3 1 7 robust co-expression networks during neurodevelopment processes, which was most 3 1 8 prominent in frontal cortex regions ( Fig. 1f, g) . There was no significant difference in 3 1 9
the number of recessive calls between patients and controls, even after stratifying the 3 2 0 calls into disease-related gene sets ( Fig. 2a and Additional file: Figure S6 ). This result 3 2 1 suggests following: (i) although categorized as "neurodevelopmental", our patient set is allele frequency values and marginally increased evolutionary conservation as 3 2 7 compared to dominant variants, suggesting that the qualitative differences between 3 2 8 these two groups of variants were not dramatically different (Fig. 2c, d 
